3651 results for «511»

Filter By

3651 results

Redo TAVI

12 Sep 2025 – From PCR Rio Valves 2025

This session focuses on the challenges and strategies of redo TAVI, from careful planning to valve selection and tailored procedural approaches. Learn how to manage different valve platforms, optimise outcomes in valve-in-valve scenarios, and prevent complications such as coronary obstruction through real case discussions.

Redo TAVI

Expanding horizons with balloon-expandable TAVI - LIVE Case

12 Sep 2025 – From PCR Rio Valves 2025

A 76-year-old male with a history of abdominal and iliac stent grafts (2022), severe COPD, prostate cancer, and gastric ulcer presented with symptomatic severe aortic stenosis. CT and echocardiography showed a calcified bicuspid aortic valve with preserved LV function.

A 24.5 mm Myval valve was implanted without...

Expanding horizons with balloon-expandable TAVI - LIVE Case

TAVI in challenging scenarios, diving into real-life cases

12 Sep 2025 – From PCR Rio Valves 2025

Navigate the complexities of challenging TAVI cases through real-life clinical scenarios. This session offers valuable insights into managing complications such as aortic regurgitation, bicuspid valves, valve-in-valve procedures, coronary obstruction, and large annulus with left ventricular outflow tract calcification. Participants will gain practical tips and tricks to...

TAVI in challenging scenarios, diving into real-life cases

Orthotopic mitral devices coming soon

12 Sep 2025 – From PCR Rio Valves 2025

This session provides a forward-looking perspective on emerging orthotopic mitral valve devices for repair and replacement. Discussions focus on new device technologies soon to be available, patient selection criteria, and the specific developmental challenges encountered. Case presentations, including the TVMR Intrepid system, illustrate clinical applications and...

Orthotopic mitral devices coming soon

Management of residual and recurrent mitral regurgitation after TEER

12 Sep 2025 – From PCR Rio Valves 2025

Delve into the complexities of managing residual and recurrent mitral regurgitation following Transcatheter Edge-to-Edge Repair (TEER). This session discusses challenges such as late mitral regurgitation, strategies for handling single leaflet detachment, and anatomical considerations that may preclude TEER feasibility.

Management of residual and recurrent mitral regurgitation after TEER

Integrating the newest valve guidelines into daily clinical reality

12 Sep 2025 – From PCR Rio Valves 2025

Integrate the 2025 EACTS valve guidelines into your clinical practice with a focus on valvular heart disease management tailored to Latin American realities. This session reviews the most relevant updates on aortic stenosis management and transcatheter approaches for mitral and tricuspid valves.

Watch the interview with Fabien...

Integrating the newest valve guidelines into daily clinical reality

TAVI - Take the first step considering life time management

12 Sep 2025 – From PCR Rio Valves 2025

Understand the critical importance of lifetime management in TAVI, emphasizing how the initial procedure impacts long-term results. This session discusses implantation depth, commissural alignment, and their roles beyond coronary access, illustrated through a low-risk young patient case and current durability data.

TAVI - Take the first step considering life time management

Mitral valve TEER echocardiography

29 Sep 2025 – From PCR Gulf Valves 2025

Gain essential knowledge in mitral valve TEER echocardiography through this comprehensive session focused on key echocardiographic views, image optimization for screening, criteria for suitability, and intraprocedural guidance. Enhance your skills with practical hands-on components aimed at improving procedural outcomes.

COVID-19: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

07 Jan 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

COVID-19: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

When transfemoral TAVI is not an option: rethinking alternative access strategies

18 Jun 2026

In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...

Author

Ulrich Schaefer
Alternative access, if transfemoral is not working

Europa Group's General Terms and Conditions of Sale

12 Apr 2024

Ref 02P - Updated June 2024

Didn’t find what you were looking for?